<unk>  is a drug used in the treatment of gastroesophageal reflux disease.<unk>  is a novel systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum.<unk>  is currently marketed in Japan (Aplace), China (Shuqi), South Korea (Defensa), and India (Troxip). It is used for the management of gastric ulcers, and amelioration of gastric mucosal lesions in acute gastritis and acute exacerbation of chronic gastritis.
Troxipide
Estropipate 
Fipexide
Tesamorelin
Progabide
Deslorelin
Sermorelin
Macimorelin